March 09, 2026

Diabetes Risk Assessment: A New Approach

Blood-based epigenetic markers show strong prognostic potential for Type 2 diabetes

The Pathologist

March 09, 2026

Blood Test Forecasts Alzheimer's Onset

Plasma p-tau217 “clocks” estimate timing of symptoms years before clinical diagnosis

The Pathologist

February 27, 2026

Cervical Cancer Is Preventable – So Why Do We Miss It?

A gynecologic oncologist explores new diagnostic priorities

The Pathologist

February 26, 2026

The Test That Could Save Patients' Bladders

Blood and urine tumor DNA monitoring may identify patients who can safely avoid cystectomy

The Pathologist

February 24, 2026

The Most Sensitive Cancer Blood Test Yet

A CRISPR-powered light sensor detected trace amounts of cancer biomarkers in the blood

The Pathologist

February 23, 2026

Dissecting Standards

Examining the case for the regulation of grossing personnel

The Pathologist

February 19, 2026

Lead Exposure Implicated in Rising Alzheimer's Rates

US study finds that patients with high bone lead levels are three times more likely to develop the disease

The Pathologist

February 18, 2026

Mass Spectrometry Takes on Amyloid 

New guidelines target false negatives, Congo red variability, and the growing role of mass spectrometry in amyloid typing

The Analytical Scientist

February 16, 2026

Breaking the Biomarker Bottlenecks: Part 2

Industry leaders from AstraZeneca, Leica Biosystems, and Danaher share their insights on AI’s power to democratize access to precision medicine

The Pathologist

February 10, 2026

How to Increase Efficiency in Routine Oncology NGS Workflows

Steven Stone discusses the importance of automating NGS to achieve faster turnaround with less attentive time

The Pathologist